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one case of atrioventricular block of first degree, two cases of ventricular
extrasystolies bigéminées. The echocardiadiographies are normal except for a
case of diastolic dysfunction. The standard therapeutic SST in 5 patients.
The TSM MIBI such as NMR is a good diagnostic examination and scal-
able for a proper and early treatment. Available in our institution, it enabled
us to diagnose 19% of cases of myocardial sarcoid lesions.
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Background: Patients with heart disease (HD) and syncope are at high risk
of sudden death. Implantable defibrillator (ICD) is recommended in patients
with unexplained syncope and left ventricular ejection fraction (LVEF) < 30%
or in patients with LVEF >30% and inducible ventricular tachycardia (VT).
Aim: The purpose of the study was to evaluate the prognostic significance
of QRS duration measurement in patients with HD and syncope.
Methods: 528 patients, 89 women and 439 men, mean age 65±12 years,
were admitted for syncope. All of them had an HD, either ischemic HD
(n=382) or left ventricular impairment of other origin (n=115). Holter moni-
toring, electrophysiological study and head-up tilt test were systematic. Fil-
tered QRS duration was measured at signal-averaged ECG (Fidelity 2000 of
Cardionics) (filter 40 Hz, noise level < 0.6 µV). The patients were followed
from 3 months up to 18 years (mean 5 ±4 years).
Results: Mean LVEF was 40±14%. Cardiac defibrillator was implanted in
73 patients. 30 patients died suddenly, 75 died from heart failure or were trans-
planted (n=9). Remaining patients are alive or died from non cardiac death (n= 8).
The last group differed from group who died suddenly by an higher LVEF
(42±14% vs 32±13) (p< 0.00001) and a shorter QRS duration (125±34 msec vs
144±31) (p< 0.026). They tended to be older (65±12 years vs 61±13) (p<0.09).
The alive group differed also from group who died from heart failure by an
higher LVEF (42±14% vs 33±13) (p< 0.001) and a shorter QRS duration
(125±34 msec vs 141±31) (p< 0.0033). They tended to be younger (65±12 years
vs 67±10) (p<0.08). Patients who died suddenly and those who died from heart
failure had similar LVEF and QRS duration but patients who died suddenly are
younger than patients who died from heart failure (p<0.01).
Conclusions: Low LVEF is a classical risk of worse prognosis in patients
with HD and syncope. A longer QRS duration is also a noninvasive and
simple test of worse prognosis. A QRS duration more than 125 msec had a
sensitivity of 73% and a specificity of 64% to predict cardiac mortality.
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Purpose: In heart failure with reduced ejection fraction, N-terminal pro brain
natriuretic peptide (NT-proBNP) is useful for diagnosis and prognosis, and is
higher with older age, female gender, renal failure and lower in obesity. In heart
failure with preserved ejection fraction (HFPEF), NT-proBNP is also useful for
diagnosis and prognosis, but clinical correlates are less well established.
Methods: KaRen is a multicenter prospective registry of HFPEF. Inclusion
criteria are acute presentation with Framingham symptoms and signs of heart
failure together with NT-proBNP >=300 ng/L and LVEF >=45%. The associ-
ation between clinical characteristics and log NT-proBNP was assessed with
uni- and multivariate linear regression, with backward step-wise selection
based on p<0.05.
Results: We studied 400 patients, mean (SD) age 77 (9) years, 56%
women. The table lists variables independently associated with log NT-
proBNP, their baseline values and Beta coefficients.
Conclusions: In HFPEF, NT-proBNP is determined mainly by NYHA
class and clinical signs of heart failure. Clinical signs are important predictor
of severity of disease. As in reduced EF, NT-proBNP is inversely associated
with BMI and GFR, but unlike in reduced ejection fraction, it is not associated
with age or gender.
Table – Independent associations with log T-proBP
Variable BMI GFR YHA I / II / III / IV pulmonary rales peripheral edema hepatomegaly pleural effusion
Mean (SD) or n (of 400) 29±6 63±28 2 / 28 / 159 / 211 304 277 21 92
Beta -0.39±0.01 -0.009±0.002 0.22±0.07 0.22±0.10 0.27±0.09 0.45±0.19 0.25±0.10
p < 0.0001 <0.0001 0.001 0.032 0.004 0.02 0.01
BMI, body mass index; GFR, glomerular filtration rate; YHA, ew York Heart Association Class

